Table 2.
Univariate analysis | Multivariate analysis* | ||||||
---|---|---|---|---|---|---|---|
Reference | r 2 | Regression coefficient (95% CI) | P | r 2 | Regression coefficient (95% CI) | P | |
Transit time | NA | 0.038 | −0.25† | .001 | 0.121 | −0.26 | >.001 |
(−0.39 to −0.11) | (−0.41 to −0.12) | ||||||
Initial WCC | NA | 0.032 | −0.03 | .002 | 0.121 | −0.04 | >.001 |
(−0.05 to −0.01) | (−0.06 to −0.02) | ||||||
Initial volume | NA | 0 | 0 | .664 | — | N/A | — |
(−0.01 to 0.012) | |||||||
Product type | HPC-A | 0.020 | 13.36 | .013 | — | N/A | — |
(2.85 to 23.89) | |||||||
Manipulation | Plasma reduction/none | 0.050 | −23.07 | <.001 | 0.121 | −18.5 | .001 |
(−34.42 to −11.72) | (−29.80 to −7.20) |
CI, confidence interval.
Variables included in original model: transit time, initial WCC, initial volume, product type, manipulation, processing center.
The predicted CD34+ recovery decreased by 0.25% for each additional hour of transit time.